Onconic Therapeutics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 9, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	734,528	176,537	-	-	-
Enterprise Value	681,114	152,373	-	-	-
Last Close Price	16510.00	4085.00	-	-	-
PS Ratio	15.75	11.90	-	-	-
PB Ratio	10.66	3.15	-	-	-
P/TBV Ratio	10.66	3.15	-	-	-
EV/Sales Ratio	14.60	10.27	-	-	-
Debt / Equity Ratio	0.00	0.01	-0.06	0.00	-0.02
Debt / EBITDA Ratio	0.01	-	0.13	-	-
Debt / FCF Ratio	0.02	-	0.12	-	-
Asset Turnover	0.87	0.30	0.62	0.00	-
Quick Ratio	12.64	10.61	0.71	1.06	36.08
Current Ratio	13.21	10.94	0.71	1.06	36.10
Return on Equity (ROE)	33.75%	-32.29%	-	-	-
Return on Assets (ROA)	14.36%	-6.09%	4.07%	-36.85%	-
Return on Capital (ROIC)	15.50%	-11.81%	-	-	-
Return on Capital Employed (ROCE)	18.00%	-8.50%	-39.40%	-343.70%	-44.10%
Earnings Yield	2.28%	-4.58%	-	-	-
FCF Yield	0.96%	-4.52%	-	-	-
Buyback Yield / Dilution	-	-1314.60%	90.00%	-0.94%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.